|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US6258795||WELLSTAT THERAP||Acylated uridine and cytidine and uses thereof||
(9 months from now)
|US7776838||WELLSTAT THERAP||Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides||
(4 years from now)
Treatment: Emergency treatment of adult & pediatric patients following fluorouracil or capecitabine overdose,or who exhibit early-onset,severe or life-threatening cardiac or cns toxicity or unusually severe adverse reactions within 96 hours
Click on the highlighted region to filter.